Coronavirus | Third phase human trial of Covaxin to begin in Bhubaneswar soon
Like the previous phases, half of the volunteers would receive placebo and the remaining half would be administered Covaxin.
Full Article
Coronavirus | Third phase human trial of Covaxin to begin in Bhubaneswar soon
Hindu
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...
Proactive Investors
Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) revealed that it has struck an agreement with Geneva, Switzerland-based..
-
NA Proactive news snapshot: American Resources, MagicMed Industries, AIM ImmunoTech, Water Tower Research, Genprex UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: Algernon Pharmaceuticals, Loop Insights, Esports Entertainment, BioSig Technologies …
Proactive Investors
-
NA Proactive news snapshot: Predictmedix, Goldcore Resources, Metalla Royalty & Streaming, GlobeX Data UPDATE …
Proactive Investors
-
States urged to adopt national approach: Niti Aayog on 'free vaccine'
Mid-Day
Advertisement
More coverage
COVID-19 vaccine: Odisha`s SUM hospital soon to begin Phase 3 human trial of Covaxin
Zee News
Notably, IMS and SUM Hospital is in the list of 21 medical institutes selected across the country by the Indian Council for..
-
COVID-19 vaccine: Phase 3 of human trial of Covaxin to begin at Odisha's SUM hospital soon
DNA
-
Covaxin: Bharat Biotech gets DCGI nod for Phase 3 trial of its coronavirus vaccine
Zee News
-
NA Proactive news snapshot: BTU Metals, Vuzix Corporation, Bioasis Technologies, Cabral Gold, Klondike Gold UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Cardiol Therapeutics, FansUnite Entertainment, Todos Medical, Lucky Minerals, GGX Gold, Flowr, 1933 Industries, KWESST UPDATE..
Proactive Investors